NF-κB-dependent increase in intrarenal angiotensin II induced by proteinuria

Kidney International

Volumn 68, Issue 2, 2005, Pages 464-473

  Takase, Osamu ^b   Marumo, Takeshi ^b   Imai, Naohiko ^b   Hirahashi, Junichi ^b   Takayanagi, Atsushi ^b   Hishikawa, Keiichi ^b   Hayashi, Matsuhiko ^a   Shimizu, Nobuyoshi ^b   Fujita, Toshiro ^b   Saruta, Takao ^b  

^a KEIO UNIVERSITY   (Japan)

^b NONE

Author keywords

Adenovirus; Angiotensin converting enzyme; Angiotensin converting enzyme 2; Angiotensinogen; Gene transfer; NF B; Proteinuria

Indexed keywords

ANGIOTENSIN II; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN I; ANGIOTENSINOGEN; CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE; I KAPPA B; MESSENGER RNA; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; RENIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE TRANSFER; KIDNEY INJURY; MACROPHAGE; MONOCYTE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; WESTERN BLOTTING; ADENOVIRUS; ANIMAL; FEMALE; GENETICS; KIDNEY; METABOLISM; PROTEIN INTAKE; WISTAR RAT;

ADENOVIRIDAE; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSINOGEN; ANIMALS; CARBOXYPEPTIDASES; DIETARY PROTEINS; FEMALE; I-KAPPA B PROTEINS; KIDNEY; NF-KAPPA B; PEPTIDYL-DIPEPTIDASE A; PROTEINURIA; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN; RNA, MESSENGER;

EID: 26944437123     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00424.x     Document Type: Article

References (37)

1. CAREY RM, SIRAGY HM: The intrarenal renin-angiotensin system and diabetic nephropathy. Trends Endocrinol Metab 14:274-281, 2003
2. TAAL MW, BRENNER BM: Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists. Kidney Int 57:1803-1817, 2000
3. LARGO R, GOMEZ-GARRE D, SOTO K, et al: Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria. Hypertension 33:732-739, 1999
4. MEZZANO SA, RUIZ-ORTEGA M, EGIDO J: Angiotensin II and renal fibrosis. Hypertension 38:635-638, 2001
5. NAVAR LG, HARRISON-BERNARD LM, NISHIYAMA A, et al: Regulation of intrarenal angiotensin II in hypertension. Hypertension 39:316-322, 2002
6. WOLF G, ZIYADEH FN: The role of angiotensin II in diabetic nephropathy: Emphasis on nonhemodynamic mechanisms. Am J Kidney Dis 29:153-163, 1997
7. WOLF G: Angiotensin II as a mediator of tubulointerstitial injury. Nephrol Dial Transplant 15(Suppl 6):61-63, 2000
8. REMUZZI G, RUGGENENTI P, BENIGNI A: Understanding the nature of renal disease progression. Kidney Int 51:2-15, 1997
9. EDDY AA: Proteinuria and interstitial injury. Nephrol Dial Transplant 19:277-281, 2004
10. RUIZ-ORTEGA M, ESTEBAN V, SUZUKI Y, et al: Renal expression of angiotensin type 2 (AT2) receptors during kidney damage. Kidney Int (Suppl):S21-S26, 2003
11. TAKASE O, HIRAHASHI J, TAKAYANAGI A, et al: Gene transfer of truncated IκBα prevents tubulointerstitial injury. Kidney Int 63:501-513, 2003
12. BRASIER AR, LI J, WIMBISH KA: Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. Hypertension 27:1009-1017, 1996
13. LI J, BRASIER AR: Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-κB p65) transcription factor: One mechanism for the renin angiotensin system positive feedback loop in hepatocytes. Mol Endocrinol 10:252-264, 1996
14. EDDY AA: Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 135:719-733, 1989
15. SUMITOMO M, TACHIBANA M, OZU C, et al: Induction of apoptosis of cytokine-producing bladder cancer cells by adenovirus-mediated IκBα overexpression. Hum Gene Ther 10:37-47, 1999
16. KANEGAE Y, LEE G, SATO Y, et al: Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res 23:3816-3821, 1995
17. NAITOH M, SUZUKI H, ARAKAWA K, et al: Role of kinin and renal ANG II blockade in acute effects of ACE inhibitors in low-renin hypertension. Am J Physiol 272:H679-H687, 1997
18. TOKUYAMA H, HAYASHI K, MATSUDA H, et al: Differential regulation of elevated renal angiotensin II in chronic renal ischemia. Hypertension 40:34-40, 2002
19. SHIMAMOTO K, ISHIDA H, NAKAHASHI Y, et al: A very sensitive direct radioimmunoassay system for plasma angiotensin II and its clinical application in various hypertensive diseases. Jpn Circ J 48:1228-1235, 1984
20. THOMAS WG, SERNIA C: Immunocytochemical localization of angiotensinogen in the rat brain. Neuroscience 25:319-341, 1988
21. XIE Y, NISHI S, IGUCHI S, et al: Expression of osteopontin in gentamicin-induced acute tubular necrosis and its recovery process. Kidney Int 59:959-974, 2001
22. OHKUBO H, KAGEYAMA R, UJIHARA M, et al: Cloning and sequence analysis of cDNA for rat angiotensinogen. Proc Natl Acad Sci USA 80:2196-2200, 1983
23. TSO JY, SUN XH, KAO TH, et al: Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cD-NAs: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13:2485-2502, 1985
24. KOBORI H, HARRISON-BERNARD LM, NAVAR LG: Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol 12:431-439, 2001
25. GOMEZ-GARRE D, LARGO R, TEJERA N, et al: Activation of NF-κB in tubular epithelial cells of rats with intense proteinuria: Role of angiotensin II and endothelin-1. Hypertension 37:1171-1178, 2001
26. CRACKOWER MA, SARAO R, OUDIT GY, et al: Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417:822-828, 2002
27. TIKELLIS C, JOHNSTON CI, FORBES JM, et al: Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 41:392-397, 2003
28. BITZER M, VON GERSDORFF G, LIANG D, et al: A mechanism of suppression of TGF-β/SMAD signaling by NF-κB/RelA. Genes Dev 14:187-197, 2000
29. TANG G, MINEMOTO Y, DIBLING B, et al: Inhibition of JNK activation through NF-κB target genes. Nature 414:313-317, 2001
30. VERHAGEN AM, BRAAM B, BOER P, et al: Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations. Kidney Int 56:222-231, 1999
31. FUJINAKA H, MIYAZAKI Y, MATSUSAKA T, et al: Salutary role for angiotensin in partial urinary tract obstruction. Kidney Int 58:2018-2027, 2000
32. MICHEL B, GRIMA M, COQUARD C, et al: Effects of dietary protein and uninephrectomy on renal angiotensin converting enzyme activity in the rat. Kidney Int 45:1587-1592, 1994
33. TANK JE, MOE OW, STAR RA, et al: Differential regulation of rat glomerular and proximal tubular renin mRNA following uninephrectomy. Am J Physiol 270:F776-F783, 1996
34. NISHIYAMA A, SETH DM, NAVAR LG: Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension 39:129-134, 2002
35. LOPEZ-FRANCO O, SUZUKI Y, SANJUAN G, et al: Nuclear factor-κB inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis. Am J Pathol 161:1497-1505, 2002
36. RANGAN GK, WANG Y, TAY YC, et al: Inhibition of nuclear factor-κB activation reduces cortical tubulointerstitial injury in proteinuric rats. Kidney Int 56:118-134, 1999
37. SUZUKI Y, LOPEZ-FRANCO O, GOMEZ-GARRE D, et al: Renal tubulointerstitial damage caused by persistent proteinuria is attenuated in AT1-deficient mice: Role of endothelin-1. Am J Pathol 159:1895-1904, 2001